Table 2.

Adverse Events (AEs) in Male and Female Participants

Male (n=33)Female (n=9)Total
Patients without any AEs28 (85%)6 (67%)34 (81%)
Patients with any AEs5 (15%)3 (33%)8 (19%)
Adverse events*5510
Facial or body hypertrichosis2 (6%)2 (22%)4 (9.5%)
Upper eyelid swelling1 (3%)2 (22%)3 (7.1%)
Palpitations1 (3%)1 (11%)2 (4.8%)
Leg swelling1 (3%)01 (2.4%)
  • * There was more than one adverse event in some participants.